Cargando…

Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice

Hemophilia A (HA) is a rare bleeding disorder caused by factor VIII (FVIII) deficiency due to various genetic mutations in the F8 gene. The disease severity inversely correlates with the plasma levels of functional FVIII. The treatment of HA patients is based on FVIII replacement therapy, either fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardo, Ángel, Caro, Alberto, Martínez-Carballeira, Daniel, Corte, José Ramón, Vázquez, Sonia, Palomo-Antequera, Carmen, Andreu, Alfredo, Fernández-Pardo, Álvaro, Oto, Julia, Gutiérrez, Laura, Soto, Inmaculada, Medina, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224793/ https://www.ncbi.nlm.nih.gov/pubmed/35743412 http://dx.doi.org/10.3390/jcm11123345

Ejemplares similares

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review
por: Verhagen, Marieke J. A., et al.
Publicado: (2022)

Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns
por: Martínez-Botía, Patricia, et al.
Publicado: (2021)

Clinical use of topical thrombin as a surgical hemostat
por: Lew, Wesley K, et al.
Publicado: (2008)

Hemostatic effect and distribution of new rhThrombin formulations in rats
por: Kochan, Jan, et al.
Publicado: (2014)

Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies
por: Marino, Renato
Publicado: (2023)

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy
por: Zhuang, Baoxiong, et al.
Publicado: (2015)

Use of a gelatin-thrombin hemostatic matrix in obstetrics and gynecological surgery
por: Mısırlıoğlu, Selim, et al.
Publicado: (2018)

Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations
por: Duarte, Rita Carolina Figueiredo, et al.
Publicado: (2017)

Thrombin generation and implications for hemophilia therapies: A narrative review
por: Sidonio, Robert F., et al.
Publicado: (2022)

Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States
por: Sharathkumar, Anjali, et al.
Publicado: (2023)

Effects of Thrombin-Based Hemostatic Agent in Total Knee Arthroplasty: Meta-Analysis
por: Park, Jung-Wee, et al.
Publicado: (2023)

Comparison of Two Gelatin and Thrombin Combination Hemostats in a Porcine Liver Abrasion Model
por: Lewis, Kevin M., et al.
Publicado: (2013)

Postoperative Spinal Epidural Hematoma: The Danger Caused by the Misuse of Thrombin-Containing Local Hemostatics
por: Ahn, Dong Ki, et al.
Publicado: (2017)

Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL(®), in intracranial tumor resection
por: Kamamoto, Dai, et al.
Publicado: (2020)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Gelatin-thrombin hemostatic matrix injection to salvage refractory post-renal graft biopsy bleed
por: Jain, V., et al.
Publicado: (2013)

Thrombin@Fe(3)O(4) nanoparticles for use as a hemostatic agent in internal bleeding
por: Shabanova, Emiliya M., et al.
Publicado: (2018)

Predictors for hemostatic thrombin-gelatin matrix usage in spine surgery: a multicenter observational study
por: Kato, So, et al.
Publicado: (2023)

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
por: Kim, Hyun Kyung
Publicado: (2010)

The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis
por: Wang, Chen, et al.
Publicado: (2014)

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere
por: Xuan, Fengqi, et al.
Publicado: (2017)

In Vitro Effects on Thrombin of Paris Saponins and In Vivo Hemostatic Activity Evaluation of Paris fargesii var. brevipetala
por: Wen, Feiyan, et al.
Publicado: (2019)

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
por: Valke, Lars L.F.G., et al.
Publicado: (2020)

In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype
por: Verhagen, Marieke J.A., et al.
Publicado: (2023)

Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model
por: Pittman, Debra D., et al.
Publicado: (2022)

Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control
por: Bruckner, Brian A., et al.
Publicado: (2021)

Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation
por: Ramón-Núñez, Luis A., et al.
Publicado: (2017)

Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition
por: Doshi, Bhavya S., et al.
Publicado: (2012)

Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents
por: Saito, Makoto, et al.
Publicado: (2018)

Peri‐operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis
por: Yagyuu, Takahiro, et al.
Publicado: (2022)

Efficacy of Intra-Articular Injection of Thrombin-Based Hemostatic Agent in the Control of Bleeding after Primary Total Knee Arthroplasty
por: Bae, Ki-Cheor, et al.
Publicado: (2014)

Diagnostic Accuracy in Acute Venous Thromboembolism: Comparing D-Dimer, Thrombin Generation, Overall Hemostatic Potential, and Fibrin Monomers
por: Farm, Maria, et al.
Publicado: (2020)

Gelatin–thrombin Hemostatic Matrix-related Cyst Formation after Cerebral Hematoma Evacuation: A Report of Two Cases
por: YAMAGUCHI, Izumi, et al.
Publicado: (2021)

Hemostatic Effects of Raloxifene in Ovariectomized Rats
por: Alva-Chavarría, Denys, et al.
Publicado: (2023)

Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes
por: Mathews, Natalie, et al.
Publicado: (2022)

Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study
por: Windyga, Jerzy, et al.
Publicado: (2020)

Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
por: Négrier, Claude, et al.
Publicado: (2022)

Effect of Flowable Thrombin-Containing Collagen-Based Hemostatic Matrix for Preventing Pancreatic Fistula after Pancreatectomy: A Randomized Clinical Trial
por: Park, Yejong, et al.
Publicado: (2020)

Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
por: Young, Guy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e6d2hdvds7m3eusf27d59smsv7